Key Insights

Highlights

Success Rate

92% trial completion (above average)

Published Results

305 trials with published results (13%)

Research Maturity

1475 completed trials (62% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

5.4%

130 terminated out of 2392 trials

Success Rate

91.9%

+5.4% vs benchmark

Late-Stage Pipeline

15%

368 trials in Phase 3/4

Results Transparency

21%

305 of 1475 completed with results

Key Signals

305 with results92% success130 terminated

Data Visualizations

Phase Distribution

1,704Total
Not Applicable (1027)
Early P 1 (10)
P 1 (158)
P 2 (141)
P 3 (160)
P 4 (208)

Trial Status

Completed1,475
Unknown348
Recruiting180
Terminated130
Not Yet Recruiting89
Active Not Recruiting71

Trial Success Rate

91.9%

Benchmark: 86.5%

Based on 1475 completed trials

Clinical Trials (2392)

Showing 20 of 20 trials
NCT07488767Not ApplicableEnrolling By Invitation

Food Sequencing in Food Insecurity

NCT07644910Not ApplicableNot Yet Recruiting

Nudging Preventive Screening Via Message Framing and Bundling

NCT07011147Not ApplicableRecruiting

Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery

NCT01179815RecruitingPrimary

Swiss Diabetes Registry - SwissDiab Study

NCT07635953Phase 3Not Yet RecruitingPrimary

New Triple Combination Therapy in Newly Diagnosed Type 2 Diabetes

NCT07631273Not ApplicableNot Yet Recruiting

Adjunctive Hyaluronic Acid Gel in Non-Surgical Periodontal Treatment of Patients With Diabetes Mellitus

NCT01934660CompletedPrimary

Links Between Inflammation and Cardiometabolic Diseases

NCT07625254Not ApplicableNot Yet RecruitingPrimary

Evaluation of Arts-Based Storytelling Program in Adolescents With Diabetes

NCT00342927Active Not Recruiting

Family Investigation of Nephropathy and Diabetes (F.I.N.D.)

NCT00001987RecruitingPrimary

Genetic Studies of Insulin and Diabetes

NCT06292962Not ApplicableCompletedPrimary

Use of taVNS for Painful Diabetic Neuropathy: 12-Week Randomized, Sham-Controlled Trial

NCT07624266CompletedPrimary

Comparison of First and Second Capillary Blood Drops for Blood Glucose Measurement

NCT05880810Not ApplicableRecruitingPrimary

Continuous Glucose Monitor for Mayo Clinic Advanced Care at Home Patients

NCT03520660Phase 4Active Not RecruitingPrimary

People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents

NCT07621419RecruitingPrimary

Study of Adult Patients Residing in Argentina Diagnosed With Type 2 Diabetes Treated With a New Formulation of Semaglutide, Both Oral and Subcutaneous, in a Real-world Setting at 3 Months, 6 Months, and 1 Year of Follow-up, Quantifying the Reduction in Glycated Hemoglobin

NCT01533142Completed

Bariatric Surgery on the West Coast of Norway (Vestlandet)

NCT07533175Phase 3RecruitingPrimary

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

NCT07621445RecruitingPrimary

Genetic Risk Score of Type 1 Diabetes Mellitus for Progression to Insulin in Diabetic Patients Lack of Predictive Value: a Multicenter Nested Case-control Study

NCT07039981Not ApplicableCompletedPrimary

Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Adults With Type 2 Diabetes

NCT05543720Not ApplicableActive Not Recruiting

Evaluation of Nurse-led Integrated Care of Complex Patients Facilitated By Telemonitoring: The SMaRT Study

Scroll to load more

Research Network

Activity Timeline